Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults (Q40490986)

21 September 2017

Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults (English)

1 reference

21 September 2017

0 references

0 references

9

Julia L Hurwitz

1 reference

21 September 2017

7

Allen Portner

1 reference

21 September 2017

1

Karen S Slobod

1 reference

21 September 2017

Jerry L Shenep

2

1 reference

21 September 2017

Jorge Luján-Zilbermann

3

1 reference

21 September 2017

Kim Allison

4

1 reference

21 September 2017

Brita Brown

5

1 reference

21 September 2017

Ruth Ann Scroggs

6

1 reference

21 September 2017

Chris Coleclough

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

21 September 2017

1 reference

21 September 2017

22

1 reference

21 September 2017

3182-3186

1 reference

21 September 2017

23-24

1 reference

Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acid sequences and antigenic and structural determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

Strategies of immunization against mucosal infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

Parainfluenza type 1 virus-infected cells are killed by both CD8+ and CD4+ cytotoxic T cell precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.053

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.01.053

1 reference

21 September 2017

1 reference